NCT03269981View on ClinicalTrials.gov

Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

827

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

December 30, 2029

Study Completion Date

December 30, 2029

Conditions
Breast Neoplasm
Interventions
RADIATION

Whole breast irradiation

Radiotherapy to the whole breast alone.

RADIATION

Whole breast and nodal irradiation

Radiotherapy to the whole breast and regional lymph nodes.

Trial Locations (1)

06351

Samsung Medical Center, Seoul

All Listed Sponsors
collaborator

Korean Radiation Oncology Group

UNKNOWN

collaborator

Ministry of Health, Republic of Korea

OTHER_GOV

lead

Samsung Medical Center

OTHER

NCT03269981 - Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer | Biotech Hunter | Biotech Hunter